Metformin and Cancer, an Ambiguanidous Relationship

The deregulation of energetic and cellular metabolism is a signature of cancer cells. Thus, drugs targeting cancer cell metabolism may have promising therapeutic potential. Previous reports demonstrate that the widely used normoglycemic agent, metformin, can decrease the risk of cancer in type 2 dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Skuli, Sarah J., Alomari, Safwan, Gaitsch, Hallie, Bakayoko, A’ishah, Skuli, Nicolas, Tyler, Betty M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144507/
https://www.ncbi.nlm.nih.gov/pubmed/35631452
http://dx.doi.org/10.3390/ph15050626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144507/
https://www.ncbi.nlm.nih.gov/pubmed/35631452
http://dx.doi.org/10.3390/ph15050626

Ejemplares similares